An Orphan Program

January 10, 2015 8:41 am
0 Comments comment
Orphan Program

By Bob Hecker Like orphan malignancies generally, sarcomas are uncommon, and research into their causes and treatment are underfunded. They are a broad and heterogeneous group of cancers that make up less than 1 percent of adult malignancies and about 10 percent of childhood cancers. Sarcomas arise from cells that resemble those that compose bone and a variety of soft tissues. Skeletal sarcomas include osteosarcoma, chondrosarcoma and Ewing sarcoma. Soft-tissue...
Read More

Match Game: Precision Cancer Medicine

January 6, 2015 8:16 am
0 Comments comment
Sameek Roychowdhury, MD

Precision cancer medicine is moving into the clinic to identify the right drug for the right patient based on tumor genomics. BY DARRELL E. WARD “Precision cancer medicine” refers to a new standard of cancer care based on genomics that is making its way into the clinic. “‘Precision’ refers to the use of genomic technologies that provide additional information to aid cancer diagnosis and treatment,” says Sameek Roychowdhury, MD,...
Read More

GOLDEN ARCHES: False Pedicle Surgery Allows for Advanced Spinal/Pelvic Reconstruction

January 4, 2015 8:31 am
0 Comments comment
Dr. Ehud Mendel

A multidisciplinary team at the OSUCCC – James has pioneered a surgical technique that used false pedicles to reconstruct a load-bearing pelvic/spine structure to support and protect the spine following a complex cancer surgery. Ehud Mendel, MD, FACS, and his colleagues built the false pedicles after en bloc resection to treat iliosacral chondrosarcoma with lumbar spine. “Primary bone tumors such as chondrosarcomas must be removed completely intact; otherwise, the...
Read More

Tobacco Control

December 28, 2014 8:56 am
0 Comments comment
Shields and Wewer

An Ohio State center provides rapid, robust science to support the FDA’s new role in tobacco regulation In September 2013, a joint program between the Food and Drug Administration (FDA), the National Institutes of Health and the National Cancer Institute awarded The Ohio State University a five-year, $18.7 million grant (CA180908) to establish the Center of Excellence in Regulatory Tobacco Science (CERTS). The center investigates the diverse and changing...
Read More